Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2015-08-04 Director's Dealing
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2015-08-04 English
FORM 4 SUBMISSION
Director's Dealing
2015-06-22 English
FORM 4 SUBMISSION
Director's Dealing
2015-06-19 English
FORM 3 SUBMISSION
Director's Dealing
2015-06-19 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the appointment of a new director to the board, details about her compensation and indemnification agreement, and the results of a shareholder vote on various proposals at the annual meeting. The key focus is on changes in the company's board of directors and the voting results from the annual meeting. There are no financial statements or detailed financial performance data included, so it is not an Annual Report (10-K) or Interim Report (IR). The document is not a proxy solicitation or presentation but rather a formal announcement of board changes and voting results. Therefore, the classification best fitting this document is Board/Management Information (MANG), as it announces changes in the company's board of directors and related governance matters. Confidence is high given the clear content and form type.
2015-06-19 English
FORM 4 SUBMISSION
Director's Dealing
2015-06-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.